Omnicom Health Group

Omnicom Health Group operates as a comprehensive healthcare communications network within the Omnicom marketing and advertising conglomerate. The group consolidates multiple specialized agencies focused exclusively on healthcare and life sciences marketing, including Area 23, FCB Health, Biolumina, Remedy Edge, Neon, Propeller, Adelphi, and Snow Companies.

The organization provides a full spectrum of services spanning healthcare professional advertising, consumer health marketing, medical communications, market access strategy, patient engagement, and evidence generation. Leveraging Omnicom's data capabilities through Acxiom integration, the group delivers life sciences-specific data analytics and insights. The network maintains global operations with dedicated leadership for North America, UK & EU, Asia Pacific, Spain, Canada, and Germany.

Omnicom Health Group positions itself as serving key healthcare stakeholders across the pharmaceutical and medical device industries, with specialized capabilities in both branded and unbranded communications for healthcare professionals, patients, and payers.

Organizations should consider Omnicom Health Group when they require the resources and global reach of a major agency network combined with healthcare-specific expertise. The group excels in coordinating complex, multi-stakeholder campaigns that span different audiences (HCPs, patients, payers) and geographies.

Expect a structured engagement model with access to specialized sub-agencies matched to specific needs, supported by enterprise-grade data analytics and insights capabilities. The network structure allows clients to tap different specialties while maintaining strategic coordination across initiatives.

Omnicom Health Group operates exclusively in healthcare and life sciences marketing communications. The network structure reflects healthcare industry segmentation with dedicated agencies for healthcare professional communications, consumer health advertising, medical and scientific communications, market access strategy, and patient engagement. The organization leverages life sciences-specific data from Acxiom to inform targeting and messaging strategies across pharmaceutical, biotechnology, and medical device verticals.

Enterprise pharmaceutical companies, major biotechnology firms, and large medical device manufacturers with complex, global marketing needs. Organizations launching new therapies requiring coordinated campaigns across multiple stakeholders, or those managing portfolios of products requiring different specialty approaches across consumer, HCP, payer, and medical affairs audiences.